Volume 27, Number 9—September 2021
Research
Risk for Acquiring Coronavirus Disease Illness among Emergency Medical Service Personnel Exposed to Aerosol-Generating Procedures
Table 2
Characteristic | All encounters | AGP encounters | Non–AGP encounters |
---|---|---|---|
Unique EMS providers |
1,592 |
567 |
1,025 |
EMS encounters | 1,115 | 182 | 933 |
ALS unit dispatched | 171 (15.3) | 98 (53.8) | 73 (7.8) |
EMS suspicion of COVID-19 | 715 (64.1) | 132 (72.5) | 583 (62.5) |
Low-flow oxygen |
188 (16.9) |
34 (18.7) |
154 (16.5) |
AGP types | |||
Nonrebreather | 139 (12.5) | 139 (76.4) | NA |
Simple face mask | 5 (0.4) | 5 (2.7) | NA |
Medication therapy | 13 (1.2) | 13 (7.1) | NA |
Metered dose inhaler | 4 (0.4) | 4 (2.2) | NA |
Nebulizer | 9 (0.8) | 9 (4.9) | NA |
NiPPV | 48 (4.3) | 48 (26.4) | NA |
CPAP | 6 (0.5) | 6 (3.3) | NA |
Bag-valve-mask ventilation | 42 (3.8) | 42 (23.1) | NA |
Suction | 4 (0.4) | 4 (2.2) | NA |
Advanced airways | 32 (2.9) | 32 (17.6) | NA |
Supraglottic airway | 3 (0.3) | 3 (1.6) | NA |
Endotracheal intubation |
29 (2.6) |
29 (15.9) |
NA |
AGP frequency per encounter | |||
0 | 933 (83.7) | 0 | 933 (100) |
1 | 138 (12.4) | 138 (75.8) | NA |
≥2 |
44 (3.9) |
44 (24.2) |
NA |
Disposition | |||
Not transported | 245 (22.0) | 21 (11.5) | 224 (24.0) |
BLS transport | 759 (68.1) | 108 (59.3) | 651 (69.8) |
ALS transport | 86 (7.7) | 53 (29.1) | 33 (3.5) |
Private vehicle | 17 (1.5) | 0 | 17 (1.8) |
Air ambulance |
1 (0.1) |
1 (0.5) |
0 |
Patient mortality as of 2020 Dec 1 | 373 (33.5) | 103 (56.6) | 270 (28.9) |
*Values are no. (%). AGP, aerosol generating procedure; ALS, advanced life support; COVID-19, coronavirus disease; CPAP, continuous positive airway pressure; EMS, emergency medical service; NA, not applicable; NiPPV, noninvasive positive-pressure ventilation.
Page created: June 16, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.